Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.

News

BWXT Appoints Martyn Coombs to lead Nuclear Medicine Business as President, BWXT ITG Canada

06 July 2020

(LYNCHBURG, Va. – July 6, 2020) – BWX Technologies, Inc. (NYSE: BWXT) today announced that Martyn Coombs has been appointed president, BWXT ITG Canada, Inc. (BWXT ITG Canada), effective July 20, 2020. In this role, Coombs will have P&L responsibility for BWXT’s medical isotope business, based in Canada, with facilities in Kanata, Ontario and Vancouver, British Columbia. In addition to leading the existing business, Coombs will also be responsible for guiding the successful launch of BWXT’s technetium-99m generator product line currently in development, and growing the overall business. Coombs will be replacing Tom Burnett, who is retiring.


BWXT Awarded Contract to Expand TRISO Nuclear Fuel Production Line

01 July 2020

(LYNCHBURG, Va. – July 1, 2020) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its Nuclear Operations Group, Inc. subsidiary has been awarded a competitively bid contract by the Idaho National Laboratory (INL) to expand and upgrade its TRISO nuclear fuel manufacturing line.

Press Contact:

Monifa Miller
+1 519.242.8071
mamiller@bwxt.com  

Archive

Tags